Navigation Links
CWRU Dental School and UH Case Medical Center test possible oral cancer detection tool
Date:6/16/2014

CLEVELAND - Case Western Reserve University School of Dental Medicine and the Department of Otolaryngology at University Hospitals Case Medical Center will collaborate on a pilot study to examine whether an abundance of naturally occurring antibacterial proteins in the mouth can predict the development of oral cancers.

The researchers will investigate how high levels of human beta-defensin-3 (hBD-3) in saliva and pre-cancerous tissues can be used to detect oral cancers faster and less invasively than traditional methods, said Aaron Weinberg, DMD, PhD, associate dean and chair of the Department of Biological Sciences at the dental school. They have found elevated levels of this protein in precancerous lesions and some oral cancers and it may provide early identification of these frequently asymptomatic cancers.

The hBD-3 peptide, which is found in the epithelial lining of the mouth, acts as a natural antibiotic in the body's immune system. HBD-3 prevents the estimated 700 species of bacteria as well as viruses and fungi that live in the mouth from invading the body and causing disease.

The researchers will recruit 60 participants, seeking treatment at UH Case Medical Center for possible oral cancers. They are also interested in patients with human papilloma virus (HPV), as this virus is increasingly correlated with increased incidence of head and neck cancer.

The researchers have found that hBD3 is overexpressed in the early stage of HPV and non-HPV related head and neck cancers. Dr. Weinberg's lab has developed an assay to measure hBD-3 levels in saliva, serum and tissue samples.

Weinberg, the study's lead investigator, will work with co-investigator Chad Zender, MD, FACS, from University Hospitals Case Medical Center's ENT Institute, to elucidate the role of hBD-3 in the development of HPV and non-HPV associated head and neck cancer.

"HBD3 has great potential as an important biomarker for cancerous lesions in the oral cavity," says Zender. "This protein has the potential to help us predict which lesions are non-cancerous versus those that are malignant. If we can identify which lesions are more aggressive, this could have a big impact on cure rates for this type of cancer."

The researchers hope to find a way to diagnose oral cancers in the earliest, more treatable stages, and to eventually halt cancer growth once diagnosed.

For years, researchers thought hBDs were "the good guys" in the mouth, said Weinberg, "but we are finding it isn't always so." The recent discovery by Case Western Reserve dental researcher and additional co-investigator Dr. Ge Jin has shown this not to be the case.

In tissue studies, Jin reported the disappearance of hBD-2, another innate peptide in the mouth's lining that protects against microbial challenges, and the proliferation of hBD-3 in cancerous tissues.

The finding led the dental researchers to hypothesize that an abundance of hBD-3 in saliva and tissue might be a way to diagnose oral cancers.

"Our team recently found that the HPV type most implicated in head and neck cancer promotes hBD-3 overexpression," Weinberg said.

Zender, a head and neck surgeon who treats benign and cancerous lesions of the mouth and throat, heard about Weinberg's interest in studying the hBD-3 connection to cancer. The collaboration was forged during a meeting between Weinberg and Cliff Megerian, the chair of the Department of Otolaryngology.

Their study includes several components:

  • Saliva samples will be collected and hBD-2 and hBD-3 levels will be measured to determine the ratio of the two peptides.

  • An oral rinse will capture the presence of HPV to conduct genetic testing to find out which genotypes are present in the patient's saliva. There are over 100 types of HPV that have been identified. Currently HPV 16 is the genotype most commonly associate with cancers of the head and neck.

  • Ratios of hBD2 to hBD3 in normal and lesional sites of the same patient will be determined by collecting cells by using a cone-shaped cytobrush swab.

  • Biopsies of questionable lesions will be taken to provide a diagnosis.

The researchers hope to determine the ratio of hBD-2 to hBD-3 that differentiates cancerous lesions from normal tissue, and may, one day be used as a diagnostic tool for oral cancers, Weinberg said.

"Our work will allow for a better understanding of the role hBD3 plays in the development of head and neck cancer, and help with the prompt identification and treatment of patients with oral squamous cell carcinoma," says Zender. "Our current understanding of oral cancer indicates that earlier diagnosis results in better outcomes."


'/>"/>

Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Dental X-Rays May Be Linked to Benign Brain Tumors
2. Death From Accidental Injuries Among Kids Drops 30%: CDC
3. From One Generation to the Next, Dental Care Changes
4. Does More Dental Plaque Mean Higher Chances of Dying From Cancer?
5. High Schoolers Can 'Smile' While Exploring Dental Careers at Summer Camp in Maine
6. Snoring Isn’t Sexy Member, Dr. Mark Levy attends the American Academy of Dental Sleep Medicine Meeting in Boston, MA
7. Tracy, California Coast Dental Office Opens
8. Spring Branch Dental Care Announces Incredible New Patient Offer
9. PMIC Announces Release of New CDT 2013 Dental Procedure Coding System
10. Racial Gap in Kids Dental Care Vanishing: Study
11. Plastics Chemical in Dental Fillings Might Affect Childrens Behavior: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... The Behavioral ... with an Award of Distinction, recognizing the organization as a top behavioral service ... in the areas of clinical quality, staff satisfaction, and qualifications and consumer satisfaction. ...
(Date:1/24/2017)... , ... January 24, 2017 , ... World Patent Marketing, ... its website invention store . , Retro Patents was co-founded by Craig ... that gives users access to millions of songs, acquired Soundwave from Craig in 2016. ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... United States Environmental Protection Agency (EPA) in its new recommendations of standards ... Innovation Institute has announced. , Cradle to Cradle Certified is recommended at ...
(Date:1/24/2017)... Plains, N.J. (PRWEB) , ... January 24, 2017 , ... ... helping patients for nearly six decades. She joins Dr. Robert V. Scalera, Jr., ... addition to our practice,” said Dr. Scalera, Jr., a general dentist and director of ...
(Date:1/24/2017)... ... January 24, 2017 , ... A fifth-year speaker at the 2017 ... will return to present about the state of the Affordable Care Act (ACA) with ... this year – will be hosted at Disney’s Grand Californian Hotel & Spa from ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... 24, 2017 South Korea Diabetes Care Devices ... Delivery Summary GlobalData,s new report, "South Korea ... market data on the South Korea Diabetes Care Devices ... dollars and volume (in units) within market categories - ... provides company shares and distribution shares data for the ...
(Date:1/24/2017)... Jan. 24, 2017 The blood screening market ... from USD 1.76 billion in 2016, at a CAGR ... based on technology, product & service, end user, and ... enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, ... to grow at the highest CAGR during the forecast ...
(Date:1/24/2017)... 2017  Ampronix discusses Sony,s recent run of ... Last year the company released four new medical ... that combines 4K and 3D imaging technologies, both ... The monitors deliver superior brightness, enhanced ... the  HVO-4000MT  medical recorder is able to store ...
Breaking Medicine Technology: